EP‐041
EXPERIÊNCIA COM TOCILIZUMABE EM PACIENTES INFECTADOS POR SARS‐COV2 E SÍNDROME INFLAMATÓRIA SISTÊMICA GRAVE
Luan Victor Almeida Lima, Bruno Pinheiro Aquino, Rafael Ferreira Mesquita, Luis Arthur Brasil Gadelha Farias, Cícero Allan Landim de Oliveira, Marllan Louise Matos Rodrigues, Nina Brunet Saraiva Rodrigues Ponte, Ana Livia Gomes Moreira, Eduardo Austregesi Correa, Melissa Soares Medeiros
Hospital São Camilo de Fortaleza, Fortaleza, CE, Brasil
Read
3767
Timeswas read the article
1666
Total PDF
2101
Total HTML
Article information
ISSN: 14138670Original language: Portuguese
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 89 | 24 | 113 |
| 2025 5 | 93 | 44 | 137 |
| 2025 4 | 78 | 37 | 115 |
| 2025 3 | 63 | 23 | 86 |
| 2025 2 | 63 | 21 | 84 |
| 2025 1 | 60 | 27 | 87 |
| 2024 12 | 41 | 21 | 62 |
| 2024 11 | 31 | 24 | 55 |
| 2024 10 | 38 | 24 | 62 |
| 2024 9 | 36 | 17 | 53 |
| 2024 8 | 47 | 25 | 72 |
| 2024 7 | 50 | 29 | 79 |
| 2024 6 | 45 | 27 | 72 |
| 2024 5 | 44 | 25 | 69 |
| 2024 4 | 47 | 26 | 73 |
| 2024 3 | 45 | 29 | 74 |
| 2024 2 | 43 | 33 | 76 |
| 2024 1 | 34 | 32 | 66 |
| 2023 12 | 36 | 22 | 58 |
| 2023 11 | 56 | 50 | 106 |
| 2023 10 | 36 | 37 | 73 |
| 2023 9 | 43 | 43 | 86 |
| 2023 8 | 25 | 16 | 41 |
| 2023 7 | 35 | 29 | 64 |
| 2023 6 | 25 | 17 | 42 |
| 2023 5 | 40 | 24 | 64 |
| 2023 4 | 25 | 13 | 38 |
| 2023 3 | 37 | 19 | 56 |
| 2023 2 | 39 | 25 | 64 |
| 2023 1 | 28 | 14 | 42 |
| 2022 12 | 37 | 27 | 64 |
| 2022 11 | 38 | 25 | 63 |
| 2022 10 | 37 | 29 | 66 |
| 2022 9 | 29 | 38 | 67 |
| 2022 8 | 31 | 30 | 61 |
| 2022 7 | 33 | 47 | 80 |
| 2022 6 | 31 | 30 | 61 |
| 2022 5 | 27 | 30 | 57 |
| 2022 4 | 30 | 40 | 70 |
| 2022 3 | 36 | 52 | 88 |
| 2022 2 | 28 | 47 | 75 |
| 2022 1 | 35 | 39 | 74 |
| 2021 12 | 32 | 42 | 74 |
| 2021 11 | 20 | 37 | 57 |
| 2021 10 | 21 | 40 | 61 |
| 2021 9 | 24 | 34 | 58 |
| 2021 8 | 22 | 24 | 46 |
| 2021 7 | 20 | 22 | 42 |
| 2021 6 | 35 | 52 | 87 |
| 2021 5 | 47 | 58 | 105 |
| 2021 4 | 83 | 103 | 186 |
| 2021 3 | 33 | 23 | 56 |
Show all
